Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

CDK inhibitor PHA-793887 profiling on A2780


ABSTRACT: The effects of the CDK inhibitor PHA-793887 on the A2780 human adenocarcinoma ovary cell line were analysed by gene expression profiling. The A2780 cell line was treated with PHA-793887 (CDK-887) for 6 hours at a dose equal to 5 time the IC50. Untreated A2780 cells were used as a control. Two replicates per treatment.

ORGANISM(S): Homo sapiens

SUBMITTER: Roberta Bosotti 

PROVIDER: E-GEOD-18498 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Discovery of drug mode of action and drug repositioning from transcriptional responses.

Iorio Francesco F   Bosotti Roberta R   Scacheri Emanuela E   Belcastro Vincenzo V   Mithbaokar Pratibha P   Ferriero Rosa R   Murino Loredana L   Tagliaferri Roberto R   Brunetti-Pierri Nicola N   Isacchi Antonella A   di Bernardo Diego D  

Proceedings of the National Academy of Sciences of the United States of America 20100802 33


A bottleneck in drug discovery is the identification of the molecular targets of a compound (mode of action, MoA) and of its off-target effects. Previous approaches to elucidate drug MoA include analysis of chemical structures, transcriptional responses following treatment, and text mining. Methods based on transcriptional responses require the least amount of information and can be quickly applied to new compounds. Available methods are inefficient and are not able to support network pharmacolo  ...[more]

Similar Datasets

2010-07-14 | E-GEOD-18552 | biostudies-arrayexpress
2010-07-14 | E-GEOD-18486 | biostudies-arrayexpress
2010-07-14 | E-GEOD-18501 | biostudies-arrayexpress
2010-07-14 | E-GEOD-18504 | biostudies-arrayexpress
2010-07-14 | E-GEOD-19638 | biostudies-arrayexpress
2010-07-14 | GSE18486 | GEO
2010-07-14 | GSE18498 | GEO
| PRJNA123779 | ENA
| PRJNA123775 | ENA
2010-07-14 | GSE18501 | GEO